Risk Perception Associated With Covid-19 Among Anesthetists

RISK PERCEPTION ASSOCIATED WITH COVID-19 PANDEMIC AMONG ANESTHETISTS: A Cross-Sectional Study

Since the outbreak of the COVID-19 pandemic, the anesthesiologists are involved in the riskiest interventions e.g. airway management, endotracheal intubation, and resuscitation. So, they are subjected to a higher risk of infection compared to many other medical specialties. As a result, they are more subjected to psychological stresses. This study aimed to assess the level of stress associated with the COVID-19 pandemic among anesthesiologists.

Study Overview

• Status: Recruiting
• Conditions: Cross Sectional Hospital Based Study
• Intervention / Treatment: Behavioral: Survey

Detailed Description

This is a cross-sectional, hospital-based survey conducted using an online questionnaire after getting IRB approval. The primary outcomes are to evaluate the prevalence of anxiety, depression, and post-traumatic stress disorder (PTSD) among anesthesiologists working in Saudi Arabia. The secondary outcomes include the association of the socio-demographic and occupational characteristics with mental health in the study sample. The survey sent to the target participants using a web-based software platform (https://www.surveymonkey.com/r/ZJ98BTJ) though the Saudi Society of Anesthesia. The study sample included anesthetists and their allied health care providers (nurses and technicians) involved in the management of COVID-19 patients. Data were analyzed using SPSS version 21. Descriptive analyses were conducted, and the ranked data for each level for symptoms of depression, anxiety, and PTSD were presented as numbers and percentages. Multi-variable logistic regression analysis was used to explore potential influence factors on the outcomes. P-values of less than 0.05 were considered statistically significant.

• Study Type: Observational
• Enrollment (Anticipated): 1000

Contacts and Locations

• Study Contact: Name: SALAH N. EL-TALLAWY, MD; Phone Number: +966557931195; Email: salaheltallawy@yahoo.com
• Study Contact Backup: Name: Maher A Titi, MSc; Phone Number: +966568310277; Email: mahertiti1980@gmail.com

Study Locations

• Saudi Arabia
  • Riyadh, Saudi Arabia, 7805
    • Recruiting
    • Salah N. El-Tallawy
    • Contact: SALAH N. EL-TALLAWY; Phone Number: 0114692191

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 65 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

• Participants' demographic variables such as gender, age, years of experience, educational degree, position at the hospital, unit of work and hospital type.
• Outcome variables: The prevalence of Anxiety, Depression and Posttraumatic Stress Disorder (PTSD)

Description

Inclusion Criteria:

• The survey included anesthesia physicians, anesthesia technicians and nurses, and those involved in the management of COVID-19 infected patients in the OR, ICU, or ER.

Exclusion Criteria:

• The exclusion criteria include age < 18 or > 60 years, incomplete data, or those who were outside Saudi Arabia during the time of the COVID-19 pandemic.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
- The prevalence of Anxiety, Depression, and Posttraumatic Stress Disorder (PTSD) among anesthesiologists during COVID-19 pandemic.	Online survey	2 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
- Comparison of the prevalence of anxiety, depression, and level of stress among different groups e.g. males # females, different occupations, single # married, young, middle-aged # geriatrics	Online survey	2 weeks

Collaborators and Investigators

• Sponsor: King Saud University
• Investigators: Principal Investigator: SALAH N. EL-TALLAWY, MD, KING SAUD UNIVERSITY, Riyadh, Saudi Arabia

Study record dates

Study Major Dates

• Study Start (Actual): April 15, 2021
• Primary Completion (Anticipated): May 5, 2021
• Study Completion (Anticipated): May 15, 2021

Study Registration Dates

• First Submitted: April 25, 2021
• First Submitted That Met QC Criteria: April 25, 2021
• First Posted (Actual): April 27, 2021

Study Record Updates

• Last Update Posted (Actual): April 27, 2021
• Last Update Submitted That Met QC Criteria: April 25, 2021
• Last Verified: April 1, 2021

More Information

Terms related to this study

• Keywords: COVID-19 pandemic, Anesthetists, Psychological stress, Anxiety, Depression, PTSD
• Additional Relevant MeSH Terms: Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; COVID-19
• Other Study ID Numbers: IRB approval No. E-20-4975

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No